The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hologic, Inc shares valued at $540,864 were sold by Stamoulis Christiana on Oct 20 ’25. At $73.07 per share, Stamoulis Christiana sold 7,402 shares. The insider’s holdings dropped to 47,336 shares worth approximately $3.54 million following the completion of this transaction.
Also, Stamoulis Christiana purchased 7,402 shares, netting a total of over 540,864 in proceeds.
Before that, MACMILLAN STEPHEN P had sold 138,358 shares from its account. In a trade valued at $9,266,118, the Chairman, President and CEO traded Hologic, Inc shares for $66.97 each. Upon closing the transaction, the insider’s holdings decreased to 138,358 shares, worth approximately $92.35 million.
As published in a research note from BNP Paribas Exane on November 21, 2025, Hologic, Inc [HOLX] has been rated down from an Outperform to a Neutral and the price target has been revised to $79. Analysts at Evercore ISI upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in early October. As of August 18, 2025, Argus has increased its “Hold” rating to a “Buy” for HOLX. Earlier on August 06, 2025, RBC Capital Mkts upgraded its rating. Their new recommendation was “an Outperform” for HOLX stock which previously was a “a Sector perform”.
Analyzing HOLX Stock Performance
On last trading session, Hologic, Inc [NASDAQ: HOLX] plunged -0.11% to $74.8. The stock’s lowest price that day was $74.685, but it reached a high of $74.92 in the same session. During the last five days, there has been a surge of approximately 0.85%. Over the course of the year, Hologic, Inc shares have dropped approximately -5.28%. Shares of the company reached a 52-week high of $74.98 on 11/25/25 and a 52-week low of $51.90 on 05/06/25.
Support And Resistance Levels for Hologic, Inc (HOLX)
According to the 24-hour chart, there is a support level at 74.68, which, if violated, would cause prices to drop to 74.57. In the upper region, resistance lies at 74.92. The next price resistance is at 75.04. RSI (Relative Strength Index) is 70.16 on the 14-day chart, showing overbought technical sentiment.
Is Hologic, Inc subject to short interest?
Stocks of Hologic, Inc saw a sharp rise in short interest on 2025-11-14 jumping by 0.38 million shares to 3.89 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 3.5 million shares. A jump of 9.89% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.84 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.84.
Which companies own the most shares of Hologic, Inc (HOLX)?
In terms of Hologic, Inc share price expectations, FactSet research, analysts set an average price target of 78 in the next 12 months, up nearly 4.17% from the previous closing price of $74.88. Analysts anticipate Hologic, Inc stock to reach 79 by 2025, with the lowest price target being 76. In spite of this, 10 analysts ranked Hologic, Inc stock as Buy at the end of 2025. On July 09, 2025, Citigroup assigned a price target of “a Buy” to the stock and upgraded coverage with a $80.
